Skip to Main Content

Paper Details

Lung Cancer Driven by BRAF<sup>G469V</sup> Mutation Is Targetable by EGFR Kinase Inhibitors.
J Thorac Oncol
14
2022
Author NameAffiliation
Ni LiuPrincess Margaret Cancer Centre, University Health Network, University of Toronto
Nhu-An PhamPrincess Margaret Cancer Centre, University Health Network
Ming LiPrincess Margaret Cancer Centre, University Health Network
Ni LiuPrincess Margaret Cancer Centre, University Health Network
Frances A ShepherdPrincess Margaret Cancer Centre, University Health Network
Nadeem MoghalPrincess Margaret Cancer Centre, University Health Network
Ming-Sound TsaoPrincess Margaret Cancer Centre, University Health Network, University of Toronto
  • 1 - 7

Datasets

Release 1.2